Volta
Is standby therapy for Covid-19 a practical option for travellers?
Unknown authors
· 2022
hash_id: a0bd085fb149dc7931c5f4d7072f420c2ef421c22955cff8934e946ac3ade01e
· DOI: 10.1093/jtm/taac111
International travel has resumed while the risk of SARS-CoV-2 persists, leading to consideration of medications that can treat or prevent Covid-19 when travellers become ill abroad. Nirmatrelvir-ritonavir, molnupiravir and tixagevimab-cilgavimab are available under Emergency Use Authorization or conditional approval. We discuss the potential application of these medications to protect travellers.
Reference & gravity metrics
Citations
0
Citations / yr
0.00
RCR
Mass
0.00
Depth
0.00
Momentum
0.000
Burn rate
0.00 ATP/day
Start price
25.00 ATP
Secondary-market trade history
No secondary-market trades recorded for this Volta yet.
References (0)
No outbound references recorded.
Cited by (1)
| Travel in the Time of COVID: A Review of International Travel Health in a Globa… | secondary |